Risk Factors for Recurrent Staphylococcus aureus Bacteremia.
dc.contributor.author | Choi, Seong-Ho | |
dc.contributor.author | Dagher, Michael | |
dc.contributor.author | Ruffin, Felicia | |
dc.contributor.author | Park, Lawrence P | |
dc.contributor.author | Sharma-Kuinkel, Batu K | |
dc.contributor.author | Souli, Maria | |
dc.contributor.author | Morse, Alison M | |
dc.contributor.author | Eichenberger, Emily M | |
dc.contributor.author | Hale, Lauren | |
dc.contributor.author | Kohler, Celia | |
dc.contributor.author | Warren, Bobby | |
dc.contributor.author | Hansen, Brenda | |
dc.contributor.author | Medie, Felix Mba | |
dc.contributor.author | McIntyre, Lauren M | |
dc.contributor.author | Fowler, Vance G | |
dc.date.accessioned | 2022-02-01T20:01:11Z | |
dc.date.available | 2022-02-01T20:01:11Z | |
dc.date.issued | 2021-06 | |
dc.date.updated | 2022-02-01T20:01:10Z | |
dc.description.abstract | BackgroundTo understand the clinical, bacterial, and host characteristics associated with recurrent Staphylococcus aureus bacteremia (R-SAB), patients with R-SAB were compared to contemporaneous patients with a single episode of SAB (S-SAB).MethodsAll SAB isolates underwent spa genotyping. All isolates from R-SAB patients underwent pulsed-field gel electrophoresis (PFGE). PFGE-indistinguishable pairs from 40 patients underwent whole genome sequencing (WGS). Acute phase plasma from R-SAB and S-SAB patients was matched 1:1 for age, race, sex, and bacterial genotype, and underwent cytokine quantification using 25-analyte multiplex bead array.ResultsR-SAB occurred in 69 (9.1%) of the 756 study patients. Of the 69 patients, 30 experienced relapse (43.5%) and 39 reinfection (56.5%). Age, race, hemodialysis dependence, presence of foreign body, methicillin-resistant Staphyloccus aureus, and persistent bacteremia were individually associated with likelihood of recurrence. Multivariate risk modeling revealed that black hemodialysis patients were nearly 2 times more likely (odds ratio [OR] = 9.652 [95% confidence interval [CI], 5.402-17.418]) than white hemodialysis patients (OR = 4.53 [95% CI, 1.696-10.879]) to experience R-SAB. WGS confirmed PFGE interpretations in all cases. Median RANTES (regulated on activation, normal T cell expressed and secreted) levels in acute phase plasma from the initial episode of SAB were higher in R-SAB than in matched S-SAB controls (P = .0053, false discovery rate < 0.10).ConclusionThis study identified several risk factors for R-SAB. The largest risk for R-SAB is among black hemodialysis patients. Higher RANTES levels in R-SAB compared to matched controls warrants further study. | |
dc.identifier | 5860449 | |
dc.identifier.issn | 1058-4838 | |
dc.identifier.issn | 1537-6591 | |
dc.identifier.uri | ||
dc.language | eng | |
dc.publisher | Oxford University Press (OUP) | |
dc.relation.ispartof | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | |
dc.relation.isversionof | 10.1093/cid/ciaa801 | |
dc.subject | Humans | |
dc.subject | Staphylococcus aureus | |
dc.subject | Bacteremia | |
dc.subject | Staphylococcal Infections | |
dc.subject | Risk Factors | |
dc.subject | Methicillin Resistance | |
dc.title | Risk Factors for Recurrent Staphylococcus aureus Bacteremia. | |
dc.type | Journal article | |
duke.contributor.orcid | Dagher, Michael|0000-0002-4305-9294 | |
duke.contributor.orcid | Ruffin, Felicia|0000-0003-2176-6462 | |
duke.contributor.orcid | Eichenberger, Emily M|0000-0002-2469-0638 | |
duke.contributor.orcid | Fowler, Vance G|0000-0002-8048-0897 | |
pubs.begin-page | 1891 | |
pubs.end-page | 1899 | |
pubs.issue | 11 | |
pubs.organisational-group | Duke | |
pubs.organisational-group | School of Medicine | |
pubs.organisational-group | Staff | |
pubs.organisational-group | Basic Science Departments | |
pubs.organisational-group | Clinical Science Departments | |
pubs.organisational-group | Institutes and Centers | |
pubs.organisational-group | Molecular Genetics and Microbiology | |
pubs.organisational-group | Medicine | |
pubs.organisational-group | Medicine, Infectious Diseases | |
pubs.organisational-group | Duke Clinical Research Institute | |
pubs.organisational-group | Institutes and Provost's Academic Units | |
pubs.organisational-group | University Institutes and Centers | |
pubs.organisational-group | Duke Global Health Institute | |
pubs.publication-status | Published | |
pubs.volume | 72 |
Files
Original bundle
- Name:
- Choi Recurrent SAB CID 2021.pdf
- Size:
- 761 KB
- Format:
- Adobe Portable Document Format